On CNBC's “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said she loves Visa Inc. V and recommends buying the stock on the dip.

The banking behemoth, on March 11, launched a new initiative aimed at tackling complex scams and preventing massive financial losses, per recent news. The company's newly formalized scam disruption practice, under its Visa Payment Ecosystem Risk and Control division, prevented over $350 million in attempted fraud in 2024 alone.

Jason Snipe of Odyssey Capital Advisors said he likes Blackstone Inc. BX, which is down 20% year-to-date.

On Feb. 27, Blackstone disclosed that Rodney Zemmel – a long-time Senior Partner at McKinsey, who served as the global leader of both McKinsey Digital and the firm’s AI Transformation initiatives – was named Global Head of Portfolio Operations.

Don't forget to check out our premarket coverage here

Kevin Simpson of Capital Wealth Planning said Eli Lilly and Company LLY has dominated the pharma space and momentum is not slowing down beyond weight loss as it has got a pipeline of Alzheimer's, oncology and autoimmune.

On March 7, Eli Lilly released new results from Ebglyss's (lebrikizumab-lbkz) long-term study, ADjoin. New data shows Ebglyss achieved deep and sustained response for patients with moderate-to-severe atopic dermatitis (eczema) at three years.

Joshua Brown of Ritholtz Wealth Management named Invitation Homes Inc. INVH as his final trade.

Supporting his view, Mizuho analyst Haendel St. Juste, on March 13, upgraded the rating for Invitation Homes from Neutral to Outperform and increased the price target from $33 to $36.

Price Action:

• Visa shares fell 1.3% to close at $328.55 on Thursday.
• Blackstone fell 2.9% to settle at $136.53 during Thursday's session.
• Eli Lilly declined 2.5% to close at $801.65 on Thursday.
• Invitation Homes shares fell 0.6% to close at $32.89 on Thursday.

Check This Out:

• Jim Cramer: Arthur J. Gallagher Is ‘Solid,’ This Industrial Company Is ‘Fantastic’

Photo: Shutterstock